Literature DB >> 12053120

Matrix metalloproteinases and their inhibitions in experimental renal scarring.

Timothy S Johnson1, John L Haylor, Graham L Thomas, Marie Fisher, A Meguid El Nahas.   

Abstract

Renal fibrosis is characterised by an excessive accumulation of extracellular matrix (ECM) proteins. Evidence suggests that this results from both increased ECM synthesis and a reduced degradation. Here, we determine changes in the matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in relation to ECM production and the progression of renal fibrosis in subtotally nephrectomized (SNx) rats. Groups of 4-6 SNx or sham-operated male Wistar rats were sacrificed between days 7 and 120 following surgery. Total RNA was analysed by Northern blotting. Messenger RNA for collagens I (+710%), III (+674%), and IV (+358%) were significantly (p < 0.05) raised by day 7 and remained elevated over the 120 days. Significant (p < 0.05) increase in fibronectin, laminin and heparan sulfate proteoglycan mRNAs occurred latter at days 60 (+224%), 120 (+210%), and 120 (+256%), respectively. Increases (p < 0.05) in mRNA for MMP-1 (+360%) and MMP-2 (+239%) occurred from day 7 with MMP-1 reaching +881% by day 120. MMP-3 and -9 showed no change. Zymography on day 90 remnant kidneys showed mRNA changes were translated into active MMP-1 (+1,700%) and MMP-2 (+440%), p < 0.05. TIMP-1 mRNA was also raised (+548%, p < 0.05) by day 7 and remained elevated, while TIMP-2 mRNA levels only reached significance by day 120 (+165%). In contrast, TIMP-3 mRNA was decreased by day 30 (p > 0.05) and dropped to 27% of control by day 120. However, Western blot analysis of TIMPs 1 and 3 at day 90 showed a 5- and 4-fold increase respectively, while TIMP-2 levels were not significantly altered. Measurements of overall collagenase activities in remnant kidney homogenates were reduced. Using collagen I and IV substrates, proteolytic activity in remnant kidneys dropped to 40 and 27% of controls (p < 0.01), respectively. This data suggests that reduced MMP activity may contribute towards renal scarring, however this is not a result of reduced MMP transcription or activation, but likely to be due to the inhibition by TIMPs. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053120     DOI: 10.1159/000058345

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  19 in total

1.  Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Authors:  Alessandra Scarpellini; Linghong Huang; Izhar Burhan; Nina Schroeder; Muriel Funck; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

2.  Expression of profibrotic genes in a murine remnant kidney model.

Authors:  Binxia Yang; Pawan K Vohra; Rajiv Janardhanan; Khamal D Misra; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2011-10-26       Impact factor: 3.464

3.  Vascular endothelial growth factor-A, matrix metalloproteinase-1, and macrophage migration inhibition factor changes in the porcine remnant kidney model: evaluation by magnetic resonance imaging.

Authors:  Sanjay Misra; Khamal D Misra; James F Glockner
Journal:  J Vasc Interv Radiol       Date:  2010-07       Impact factor: 3.464

4.  Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology.

Authors:  Michael Anne Gratton; Velidi H Rao; Daniel T Meehan; Charles Askew; Dominic Cosgrove
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

5.  Inhibition of Thrombin-Activated Fibrinolysis Inhibitor Increases Survival in Experimental Kidney Fibrosis.

Authors:  John M Atkinson; Nick Pullen; Michelle Da Silva-Lodge; Lynne Williams; Tim S Johnson
Journal:  J Am Soc Nephrol       Date:  2014-11-19       Impact factor: 10.121

6.  Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.

Authors:  Kinga Musiał; Danuta Zwolińska
Journal:  Cell Stress Chaperones       Date:  2010-09-06       Impact factor: 3.667

7.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.

Authors:  Peng Hu; Jing Wang; Xue Qi Zhao; Bo Hu; Ling Lu; Yuan Han Qin
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

Review 9.  Structural aspects of the metzincin clan of metalloendopeptidases.

Authors:  F Xavier Gomis-Rüth
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

10.  Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.

Authors:  Nagi Altemtam; Meguid El Nahas; Tim Johnson
Journal:  Nephron Extra       Date:  2012-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.